Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Ticpot 3.1gm Injection
Manufacturer/Marketed By : UNIFAITH BIOTECH PVT LTD
$13.18 $10.54
Ticpot 3.1gm Injection contains the active component Ticarcillin and Clavulanic acid. Ticarcillin is an antibiotic belonging to the penicillin class. Clavulanic acid is a beta-lactamase inhibitor. It is commonly used...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
TICARCILLIN,CLAVULANIC ACID
Active Pharmaceutical Ingredient
Ticpot 3.1gm Injection
13,18$
10,54$
Ticpot 3.1gm Injection contains the active component Ticarcillin and Clavulanic acid. Ticarcillin is an antibiotic belonging to the penicillin class. Clavulanic acid is a beta-lactamase inhibitor. It is commonly used to treat serious infections such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, and septicemia. Clavulanic acid inhibits these enzymes, thereby allowing ticarcillin (or other penicillin antibiotics) to be more effective against beta-lactamase-producing bacteria. Individuals with hypersensitivity or allergic reactions to penicillins, cephalosporins, or other beta-lactam antibiotics should not take this medication. Ticpot 3.1gm Injection is not recommended for individuals with mononucleosis (also known as the "kissing disease") or suspected viral infections, as it is primarily used to treat bacterial infections. This medication is eliminated from the body through the kidneys. Individuals with severe kidney impairment may require dose adjustments or alternative treatment options, and caution should be exercised. It contains a high amount of potassium. Individuals with hyperkalemia (high levels of potassium in the blood) need caution due to the potential for further increases in potassium levels.
Active Pharmaceutical Ingredient
Uses
• Respiratory tract infections
• Urinary tract infections (UTIs)
• Intra-abdominal infection
• Skin and soft tissue infections (cellulitis, infected wounds)
• Bone and joint infections (osteomyelitis and septic arthritis)
• Gynecological infections (pelvic inflammatory disease (PID) and postpartum endometritis)
• Septicemia and bloodstream infections
Benefits
The Ticpot 3.1gm Injection combination enhances ticarcillin's effectiveness against a wide range of bacteria. Clavulanic acid inhibits beta-lactamase enzymes that can render ticarcillin ineffective, expanding its coverage. This synergy improves treatment outcomes in bacterial infections, especially those caused by beta-lactamase-producing bacteria.
Side Effects
Ticpot 3.1gm Injection cause some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Diarrhea
• Nausea and vomiting
• Skin rash or itching
• Headache
• Abdominal discomfort or pain
• Thrush (oral or vaginal fungal infection)
Common Side Effects
• Severe allergic reactions (rash, itching, swelling, severe dizziness, difficulty breathing)
• Severe skin reactions (Stevens-Johnson syndrome or toxic epidermal necrolysis)
• Liver dysfunction
• Hepatitis
• Clostridium difficile-associated diarrhea
• Agranulocytosis (severe decrease in white blood cells)
• Thrombocytopenia (low platelet count)
How To Use
It is essential to follow the healthcare professional's instructions to use Ticpot 3.1gm Injection. The medication is typically administered via injection by a healthcare provider in a hospital setting. The dosage and duration of treatment depend on the specific infection, the patient's weight, and other individual factors.
Safety Advice
• Breast Feeding: The safety of Ticpot 3.1gm Injection during breastfeeding is not well studied, and it is recommended to exercise caution.
• Alcohol: Alcohol consumption may increase the risk of certain side effects associated with Ticpot 3.1gm Injections, such as dizziness or stomach irritation.
• Liver: Both Ticpot 3.1gm Injections can potentially cause liver toxicity as rare adverse effects. Monitoring liver function tests may be necessary during treatment.
• Lungs: Suppose you have a pre-existing lung condition or are concerned about the safety of the Ticpot 3.1gm Injection in your lungs. Consulting with your healthcare provider for personalized advice is recommended in that case.
• Driving: Ticpot 3.1gm Injection may cause dizziness or drowsiness in some individuals. If you experience these side effects, avoiding activities requiring mental alertness, such as driving or operating machinery, is important.
• Pregnancy: The use of Ticpot 3.1gm Injection during pregnancy should be discussed with the healthcare provider. They will consider the specific circumstances, the patient's medical history, and individual factors to make an informed decision.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.